Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02013583 · ClinicalTrials.gov registry record

The Glucose Transporter Type I Deficiency (G1D) Registry

A clinical trial, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
471
Enrollment target

NCT02013583: Completed study, sponsored by University of Texas Southwestern Medical Center.

NCT02013583 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 471 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02013583 has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
471 participants
Enrollment target

Study Summary

The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase the understanding of G1D and any sub-diagnoses.

Primary Outcome

It is hypothesized that symptom severity will correspond to the degree of biochemical dysfunction or mutation type (when available). A broad range of symptoms and severity ratings are collected both retrospectively and prospectively.

Interventions

  • OTHER No intervention

Trial Details

FieldValue
Enrollment Target 471 participants
Start Date 2013-12
Est. Completion 2024-08-01

What the finished NCT02013583 record still lists

NCT02013583 is an observational study that tracks outcomes without assigning an intervention. The registered 471 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT02013583 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02013583 about?

NCT02013583 is a clinical study titled "The Glucose Transporter Type I Deficiency (G1D) Registry". The purpose of this protocol is to create a registry for patients diagnosed with Glucose Transporter Type 1 Deficiency (G1D), or patients experiencing symptoms consistent with G1D but not yet diagnosed, to enter medical information for physicians and other health researchers to analyze to increase t...

What is the current status of trial NCT02013583?

This trial is currently completed. The enrollment target is 471 participants. The study started on 2013-12. Estimated completion is 2024-08-01.

What interventions are being tested in trial NCT02013583?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT02013583?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03010150 · 471 participants

    Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

  • NCT05201404 · 471 participants · Phase 3

    Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

  • NCT06375083 · 472 participants · Phase 2

    Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression

  • NCT06947187 · 472 participants · NA

    Vaccine Confidence and Infodemic in Southeast Asia's Nusantara Sociocultural Sphere

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02013583, the US trial registry maintained by the National Library of Medicine. NCT02013583 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.